Clinical Partners

Johnston, Rhode Island 12095

0 studies enrolling now · 10 studies all time

What they study most

Acne Vulgaris, Dermatitis, Atopic, Diabetes Mellitus, Hidradenitis Suppurativa, Painful Distal Symmetric Sensorimotor Polyneuropathy, Psoriasis, Psoriasis Vulgaris

Studies at this site

• An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects — Completed
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis — Completed
• A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa — Stopped early
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed
• Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris — Completed
• Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy — Status unconfirmed
• BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris — Completed
• Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy — Completed